Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nassif, A; Coevoet, V; Resten, A; Aikem, N; Maitre, S; Musse, D
   Pulmonary embolization from migration of variceal sclerosant
   JOURNAL DE RADIOLOGIE
   
   A. Nassif et al., "Pulmonary embolization from migration of variceal sclerosant", J RADIOLOG, 82(5), 2001, pp. 583-585
2. Michalon, N; Nassif, A; Saouri, T; Royer, JF; Pontikis, CA
   Contribution to the climatological study of lightning
   GEOPHYSICAL RESEARCH LETTERS
   
   N. Michalon et al., "Contribution to the climatological study of lightning", GEOPHYS R L, 26(20), 1999, pp. 3097-3100
3. Hadacek, BM; Nassif, A; Roux, A; Desplaces, N; Huerre, M; de Bievre, C; Aerts, J; Raguin, G
   Trichophyton tonsurans dermatophyte granuloma in an HIV-1 infected patient
   BRITISH JOURNAL OF DERMATOLOGY
   
   B.M. Hadacek et al., "Trichophyton tonsurans dermatophyte granuloma in an HIV-1 infected patient", BR J DERM, 140(4), 1999, pp. 762-763
4. HANIFIN JM; STORRS FJ; CHAN SC; NASSIF A
   IRRITANT REACTIVITY IN NONCUTANEOUS ATOPY
   Journal of the American Academy of Dermatology
   
   J.M. Hanifin et al., "IRRITANT REACTIVITY IN NONCUTANEOUS ATOPY", Journal of the American Academy of Dermatology, 37(1), 1997, pp. 139-139
5. NASSIF A; LONGO WE; MAZUSKI JE; VERNAVA AM; KAMINSKI DL
   ROLE OF CYTOKINES AND PLATELET-ACTIVATING-FACTOR IN INFLAMMATORY BOWEL-DISEASE IMPLICATIONS FOR THERAPY
   Diseases of the colon & rectum
   
   A. Nassif et al., "ROLE OF CYTOKINES AND PLATELET-ACTIVATING-FACTOR IN INFLAMMATORY BOWEL-DISEASE IMPLICATIONS FOR THERAPY", Diseases of the colon & rectum, 39(2), 1996, pp. 217-223
6. NASSIF A; LONGO WE; SEXE R; STRATTON M; STANDEVEN J; VERNAVA AM; KAMINSKI DL
   CLOSTRIDIUM-DIFFICILE SUPPRESSES COLONIC VASOACTIVE-INTESTINAL-PEPTIDE ASSOCIATED WITH ALTERED MOTILITY
   Mediators of inflammation
   
   A. Nassif et al., "CLOSTRIDIUM-DIFFICILE SUPPRESSES COLONIC VASOACTIVE-INTESTINAL-PEPTIDE ASSOCIATED WITH ALTERED MOTILITY", Mediators of inflammation, 4(6), 1995, pp. 452-453
7. LONGO WE; DESHPANDE Y; CHANDEL B; SEXE R; STRATTON M; NASSIF A; VERNAVA AM; KAMINSKI DL
   LIDOCAINE AMELIORATES TRINITROBENZENE SULFONIC-ACID (TNB) SUPPRESSIONOF TISSUE-LEVELS OF COLONIC NEUROPEPTIDES
   Gastroenterology
   
   W.E. Longo et al., "LIDOCAINE AMELIORATES TRINITROBENZENE SULFONIC-ACID (TNB) SUPPRESSIONOF TISSUE-LEVELS OF COLONIC NEUROPEPTIDES", Gastroenterology, 108(4), 1995, pp. 986-986
8. NASSIF A
   ABNORMAL SKIN IRRITANCY IN ATOPIC-DERMATITIS AND IN ATOPY WITHOUT DERMATITIS (VOL 130, PG 1402, 1994)
   Archives of dermatology
   
   A. Nassif, "ABNORMAL SKIN IRRITANCY IN ATOPIC-DERMATITIS AND IN ATOPY WITHOUT DERMATITIS (VOL 130, PG 1402, 1994)", Archives of dermatology, 131(4), 1995, pp. 464-464
9. SHAMKES BS; NASSIF A; BAILEY CS; SALTZSTEIN SL
   SECONDARY ANETODERMA INVOLVING A PILOMATRICOMA
   The American journal of dermatopathology
   
   B.S. Shamkes et al., "SECONDARY ANETODERMA INVOLVING A PILOMATRICOMA", The American journal of dermatopathology, 16(5), 1994, pp. 557-560
10. NASSIF A; SMITH DL; HANIFIN JM
    OLECRANON AND PRETIBIAL BURSITIS IN ATOPIC-DERMATITIS - COINCIDENCE OR ASSOCIATION
    Journal of the American Academy of Dermatology
    
    A. Nassif et al., "OLECRANON AND PRETIBIAL BURSITIS IN ATOPIC-DERMATITIS - COINCIDENCE OR ASSOCIATION", Journal of the American Academy of Dermatology, 30(5), 1994, pp. 737-742
11. NASSIF A; CHAN SC; STORRS FJ; HANIFIN JM
    ABNORMAL SKIN IRRITANCY IN ATOPIC-DERMATITIS AND IN ATOPY WITHOUT DERMATITIS
    Archives of dermatology
    
    A. Nassif et al., "ABNORMAL SKIN IRRITANCY IN ATOPIC-DERMATITIS AND IN ATOPY WITHOUT DERMATITIS", Archives of dermatology, 130(11), 1994, pp. 1402-1407